Covidien has added appointed four new executives to its research and
development (R&D) leadership team for its pharmaceutical products
and imaging solutions businesses.
Nucletron has appointed Jos Lamers as its new CEO, which marks the next
phase for the company following its management buy-out from Delft
Instruments in August 2007.
InSight Health Services Holdings has reported that Mitch C. Hill, its
executive vice president and chief financial officer (CFO), will be
leaving his position, which he has held since January 2005, effective
Oct. 31.
Nick van Terheyden, MD, has joined M*Modal as chief medical officer
(CMO), adding extensive healthcare industry experience to M*Modal, the
company said.
Previous